Our results indicated that FBXW1 was more expressed in colon adenocarcinoma (COAD), cholangiocarcinoma (CHOL), lung adenocarcinoma (LUAD), liver hepatocellular carcinoma (LIHC), Prostate adenocarcinoma (PRAD), and stomach adenocarcinoma (STAD). This evidence concerns the gene BTRC and prostate adenocarcinoma.